- Home
- BRNS vs ANEB Comparison
BRNS vs ANEB Comparison
Compare BRNS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- ANEB
- Stock Information
- Founded
- BRNS 2016
- ANEB 2020
- Country
- BRNS United Kingdom
- ANEB United States
- Employees
- BRNS N/A
- ANEB N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- BRNS Health Care
- ANEB Health Care
- Exchange
- BRNS Nasdaq
- ANEB Nasdaq
- Market Cap
- BRNS 36.7M
- ANEB 36.7M
- IPO Year
- BRNS 2021
- ANEB 2021
- Fundamental
- Price
- BRNS $1.17
- ANEB $1.32
- Analyst Decision
- BRNS Strong Buy
- ANEB Buy
- Analyst Count
- BRNS 2
- ANEB 1
- Target Price
- BRNS $4.00
- ANEB $8.00
- AVG Volume (30 Days)
- BRNS 69.8K
- ANEB 8.2K
- Earning Date
- BRNS 11-06-2024
- ANEB 02-11-2025
- Dividend Yield
- BRNS N/A
- ANEB N/A
- EPS Growth
- BRNS N/A
- ANEB N/A
- EPS
- BRNS N/A
- ANEB N/A
- Revenue
- BRNS $14,969,000.00
- ANEB N/A
- Revenue This Year
- BRNS $1,805.74
- ANEB N/A
- Revenue Next Year
- BRNS N/A
- ANEB N/A
- P/E Ratio
- BRNS N/A
- ANEB N/A
- Revenue Growth
- BRNS 106.21
- ANEB N/A
- 52 Week Low
- BRNS $0.80
- ANEB $1.25
- 52 Week High
- BRNS $4.16
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- BRNS 57.61
- ANEB 36.76
- Support Level
- BRNS $0.80
- ANEB $1.26
- Resistance Level
- BRNS $1.05
- ANEB $1.50
- Average True Range (ATR)
- BRNS 0.12
- ANEB 0.12
- MACD
- BRNS 0.03
- ANEB -0.00
- Stochastic Oscillator
- BRNS 100.00
- ANEB 13.41
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.